Nouvelles de conférencesToronto was recently the host of the Internationalconference on Alzheimer’sdisease which is held annually in different cities around theworld. There is always lot ofaction going on any given dayof the conference.The latest trial failure showsthat another approach totreating Alzheimer’s will notbe the long-sought answer,and raises concerns about the idea of using multiple drugsto treat the disease, whichrobs people of their memoriesand ability to function in theworld.The trial of the drug currentlycalled LMTM, made by TauRx,included more than 890patients from the US, Europeand elsewhere. Overall, thedrug showed no benefitcompared to typicaltreatment, which includescholinesterase inhibitors.Researchers presentedpreliminary results from asmall trial showing that 11-14hours of “brain training”designed to increasevolunteer’s processing speed,cut their risk of dementianearly in half over a decade.The computer trainingprogram, Double Decisionfrom BrainHQ, costs $96 ayear.People who had morecomplex jobs, remainedsocially active and avoideddepression were also moreresilient to the ravages ofAlzheimer’s, other newresearch confirmed.Previous research has alsosupported the importance ofeating a Mediterranean diet,exercising by taking 8,000-10,000 steps a day, sleepingat least 7-8 hours a night,and moderating stress, saidMassachusetts GeneralHospital Neurologist RudolphTanzi.“Try to learn something newand hang out with people you like, who don’t expect toomuch of you and stress youout,” said Tanzi, also aprofessor at Harvard medicalSchool.